CLOs on the Move

Foot & Ankle Specialists of the Mid-Atlantic

www.footandankle-usa.com

 
Need a podiatrist? Foot & Ankle Specialists of the Mid-Atlantic has offices all along the east coast. Contact our doctors today for additional help & information!
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Jen Searfoss
Chief Legal and Compliance Officer Profile

Similar Companies

SPARC

We are a pharma research and drug discovery company.

Absolute Biotech

Absolute Biotech is a company that specializes in antibody reagents, kits, and services, adding value to existing antibodies through annotation, validation, sequencing, engineering, and recombinant manufacturing.

NOXXON Pharma

Noxxon Pharma AG is a Germany-based biotechnology company with focus on cancer treatment. The Company develops drugs under the trademark Spiegelmer, which target the tumor microenvironment. Spiegelmers can be manufactured chemically and are a variant o...

Falks Woodland Pharmacy

Falks Woodland Pharmacy is a Duluth, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Respira Therapeutics

Respira Therapeutics, Inc., founded in 2010 with offices in Albuquerque, New Mexico, is a development stage inhaled pharmaceutical development company focused on commercializing its "best in class", high efficiency AOS-DPI, dry powder inhaler (DPI) drug delivery technology to deliver RT234, a proprietary inhaled formulation of an off patent oral drug via the lung to treatment of multiple orphan indications in the fields of pulmonary hypertension and other diseases. Investors in Respira include Cottonwood Technology Fund and Sun Mountain Capital and individual investors. To date Respira has performed extensive testing demonstrating its advanced AOS-DPI prototypes can deliver 2-3X more drug to the lung than commercially available DPI technologies. Respira is planning proof of concept clinical trials of an inhaled formulation of RT234 in pulmonary arterial hypertension patients in the near future.